VAERS reports by lot

Pfizer COVID-19 lot BNT162B2: VAERS reports

63 VAERS reports list lot BNT162B2 as a Pfizer COVID-19 vaccine, received between 2021-01-15 and 2023-04-24. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
63
Reports
8%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5724%
Cardiac / Cardiovascular4820%
Neurological2711%
Musculoskeletal2310%
Gastrointestinal208%
Allergic / Anaphylactic125%
Injection-site / Local reaction125%
Respiratory104%
Dermatological (non-injection-site)104%
Thrombotic / Hematological73%
Psychiatric / Neuropsychiatric42%
Autoimmune / Immune-mediated31%
Reproductive / Menstrual31%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York4
Illinois3
Texas2
Virginia2
California2
Ohio2
Indiana2
South Carolina1
Minnesota1
Michigan1
New Jersey1
Maine1

Reports by month received

2021-013
2021-023
2021-036
2021-043
2021-0528
2021-062
2021-071
2021-085
2021-092
2021-103
2021-115
2021-121
2023-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.